To overcome the obstacles that hyperthermic intraperitoneal chemotherapy (HIPEC) cannot effectively penetrate large tumor nodules, Lv et al. genetically engineered fibroblasts to produce CD47-expressed exosomes, which were then fused with thermosensitive liposomes (Lv et al., 2020). The gene discussed is CD47; the disease is neoplasm.